Notably, although extensive evidence implicates PKM2, YAP/TEAD, and β-catenin in renal metabolic reprogramming and fibrosis, the precise mechanisms through which PKM2 nuclear translocation coordinates with transcriptional coactivator networks to drive CKD progression remain unknown (23, 30, 31). The gene discussed is PKM; the disease is chronic kidney disease.